Literature DB >> 26088216

Central and peripheral pain generators in women with chronic pelvic pain: patient centered assessment and treatment.

Donna Hoffman1.   

Abstract

Women with chronic pelvic pain (CPP) often present without obvious cause on imaging studies, laboratory values or physical exam. Dysfunctional sensory processing in the central nervous system (CNS) may explain pain of unclear origin. Central sensitization (CS), a mechanism of centrally mediated pain, describes this abnormal processing of sensory information. Women with CPP often present with several seemingly unrelated symptoms. This can be explained by co-existing chronic pain syndromes occurring in the same patient. Central sensitization occurs in all of these pain syndromes, also described as dysfunctional pain syndromes, and thus may explain why several often occur in the same patient. Six of the most common pain disorders that co-exist in CPP include endometriosis, painful bladder syndrome/interstitial cysitis, vulvodynia, myofascial pain/ pelvic floor hypertonus, irritable bowel syndrome, and primary dysmenorrhea. Central pain generators, (pain originating from CS) and peripheral pain generators, (pain from local tissue damage), can both occur in each of these six conditions. These pain generators will be described. Chronic pain, specifically dysfunctional sensory processing, is recognized as a systemic disease process like diabetes to be managed as opposed to a local problem to be "fixed" or cured. A multi-disciplinary approach to assessment and treatment with a focus on improving emotional, physical and social functioning instead of focusing strictly on pain reduction is more effective in decreasing disability. This is best achieved by determining the patient's needs and perspective through a patient-centered approach. Algorithms for such an approach to assessment and treatment are outlined.

Entities:  

Mesh:

Year:  2015        PMID: 26088216     DOI: 10.2174/1573397111666150619094524

Source DB:  PubMed          Journal:  Curr Rheumatol Rev        ISSN: 1573-3971


  13 in total

Review 1.  Methodological approaches to botulinum toxin for the treatment of chronic pelvic pain, vaginismus, and vulvar pain disorders.

Authors:  Barbara Illowsky Karp; Hannah Tandon; Deionna Vigil; Pamela Stratton
Journal:  Int Urogynecol J       Date:  2019-01-07       Impact factor: 2.894

Review 2.  Capturing Novel Non-opioid Pain Targets.

Authors:  Clifford J Woolf
Journal:  Biol Psychiatry       Date:  2019-06-29       Impact factor: 13.382

3.  Clinical and functional impact of central sensitization on patients with familial Mediterranean fever: a cross-sectional study.

Authors:  Feyza Nur Yücel; Halise Hande Gezer; Janbubi Jandaulyet; Nuran Öz; Sevtap Acer Kasman; Mehmet Tuncay Duruöz
Journal:  Rheumatol Int       Date:  2022-08-12       Impact factor: 3.580

4.  Chronic Pelvic Pain in Endometriosis: Cross-Sectional Associations with Mental Disorders, Sexual Dysfunctions and Childhood Maltreatment.

Authors:  Johanna Netzl; Burkhard Gusy; Barbara Voigt; Jalid Sehouli; Sylvia Mechsner
Journal:  J Clin Med       Date:  2022-06-27       Impact factor: 4.964

Review 5.  [Management of endometriosis pain : Stage-based treatment strategies and clinical experience].

Authors:  Sylvia Mechsner
Journal:  Schmerz       Date:  2021-03-11       Impact factor: 1.107

6.  Anatomic Sites and Associated Clinical Factors for Deep Dyspareunia.

Authors:  Paul J Yong; Christina Williams; Ali Yosef; Fontayne Wong; Mohamed A Bedaiwy; Sarka Lisonkova; Catherine Allaire
Journal:  Sex Med       Date:  2017-08-01       Impact factor: 2.491

Review 7.  Research on central sensitization of endometriosis-associated pain: a systematic review of the literature.

Authors:  Ping Zheng; Wen Zhang; Jinhua Leng; Jinghe Lang
Journal:  J Pain Res       Date:  2019-05-08       Impact factor: 3.133

Review 8.  Neurogenic Inflammation in the Context of Endometriosis-What Do We Know?

Authors:  Renata Voltolini Velho; Eliane Taube; Jalid Sehouli; Sylvia Mechsner
Journal:  Int J Mol Sci       Date:  2021-12-03       Impact factor: 5.923

9.  A prospective, single-centre, single-arm, open label study of the long term use of a gonadotropin releasing hormone agonist (Triptorelin SR, 11.25 mg) in combination with Tibolone add-back therapy in the management of chronic cyclical pelvic pain.

Authors:  Sallwa M Alshehre; Sheila Duffy; Georgina Jones; William L Ledger; Mostafa Metwally
Journal:  Reprod Biol Endocrinol       Date:  2020-04-14       Impact factor: 5.211

Review 10.  Endometriosis, an Ongoing Pain-Step-by-Step Treatment.

Authors:  Sylvia Mechsner
Journal:  J Clin Med       Date:  2022-01-17       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.